Indaptus Therapeutics, Inc. (INDP)
2.89
-0.24
(-7.67%)
USD |
NASDAQ |
Nov 20, 12:13
Indaptus Therapeutics Free Cash Flow : -13.97M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -13.97M |
| June 30, 2026 | -15.79M |
| March 31, 2026 | -17.68M |
| December 31, 2025 | -15.72M |
| September 30, 2025 | -15.59M |
| June 30, 2025 | -15.06M |
| March 31, 2025 | -13.43M |
| December 31, 2024 | -12.31M |
| September 30, 2024 | -11.36M |
| June 30, 2024 | -12.34M |
| March 31, 2024 | -11.91M |
| December 31, 2023 | -12.93M |
| September 30, 2023 | -12.52M |
| June 30, 2023 | -13.42M |
| March 31, 2023 | -11.47M |
| December 31, 2022 | -12.59M |
| September 30, 2022 | -14.30M |
| June 30, 2022 | -15.56M |
| March 31, 2022 | -16.83M |
| December 31, 2021 | -11.57M |
| September 30, 2021 | -8.829M |
| June 30, 2021 | 1.250M |
| March 31, 2021 | 0.8933M |
| December 31, 2020 | -3.431M |
| September 30, 2020 | -5.360M |
| Date | Value |
|---|---|
| June 30, 2020 | -17.93M |
| March 31, 2020 | -27.24M |
| December 31, 2019 | -30.57M |
| September 30, 2019 | -39.62M |
| June 30, 2019 | -42.91M |
| March 31, 2019 | -41.78M |
| December 31, 2018 | -45.58M |
| September 30, 2018 | -43.30M |
| June 30, 2018 | -39.08M |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -9.336M |
| September 30, 2015 | -5.615M |
| June 30, 2015 | -6.554M |
| March 31, 2015 | -5.532M |
| December 31, 2014 | -4.51M |
| September 30, 2014 | -5.731M |
| June 30, 2014 | -4.938M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cypherpunk Technologies, Inc. | -132.19M |
| Capricor Therapeutics, Inc. | -146.29M |
| Ocugen, Inc. | -63.90M |
| Cue Biopharma, Inc. | -51.22M |
| Yarrow Bioscience, Inc. | -99.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.245M |
| Cash from Investing (Quarterly) | 0.0882M |
| Cash from Financing (Quarterly) | 20.30M |
| Free Cash Flow Per Share (Quarterly) | -0.0093 |
| Free Cash Flow to Equity (Quarterly) | -1.245M |
| Free Cash Flow to Firm (Quarterly) | -1.245M |
| Free Cash Flow Yield | -3.63% |